Latest news
Astellas files NDA for fezolinetant in Japan - The Pharma LetterThe Pharma Letter · Sat, 08 Aug 2026 13:41:15 GMTQ1 2027 Astellas Pharma Inc Earnings Presentation (Japanese) Transcript - GuruFocusGuruFocus · Fri, 07 Aug 2026 14:34:54 GMTAstellas Pharma (TSE:4503) Is Up 6.0% After Q1 Profit Surge Signals Improved Operational Efficiency - simplywall.stsimplywall.st · Fri, 07 Aug 2026 13:40:06 GMTKao And Astellas Lift Japan Earnings Traders - FinimizeFinimize · Thu, 06 Aug 2026 14:45:55 GMTAstellas Pharma (TSE:4503) Stock Can Margin Gains Outrun Patent Risks - simplywall.stsimplywall.st · Thu, 06 Aug 2026 12:26:29 GMTVir Biotechnology (NASDAQ: VIR) swings to profit on $239.3M Astellas deal - stocktitan.netstocktitan.net · Wed, 05 Aug 2026 21:21:28 GMTVIR: Q2 2026 net income reached $80.1M, fueled by Astellas collaboration and clinical progress - TradingViewTradingView · Wed, 05 Aug 2026 20:21:15 GMTAstellas Pharma: Q1 delivered record revenue and profit growth, led by strategic brands and pipeline advances - TradingViewTradingView · Wed, 05 Aug 2026 06:35:00 GMT